WVP
CLPT icon

Worth Venture Partners’s ClearPoint Neuro CLPT Stock Holding History

Worth Venture Partners’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-76,361
Closed -$272K – 123
2020
Q2 		$272K Sell
76,361
-4,550
-6% -$16.9K 0.13% 81
2020
Q1 		$290K Sell
80,911
-5,814
-7% -$28.6K 0.18% 64
2019
Q4 		$416K Buy
+86,725
New +$359K 0.2% 56

Other funds holding CLPT

MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return

Worth Venture Partners's CLPT Position: Q3 2020 in Review

Worth Venture Partners sold out of ClearPoint Neuro (CLPT) in Q3 2020, closing a stake of 76,361 shares — an estimated $272K sold.

Worth Venture Partners first reported a position in CLPT in Q4 2019 and held it in 3 quarters. The position peaked at $416K in Q4 2019. 28 funds tracked by Wall St. Rank hold CLPT as of Q3 2020.

  • Worth Venture Partners reported no remaining ClearPoint Neuro position as of Q3 2020 after selling out during the quarter.
  • Worth Venture Partners sold 76,361 ClearPoint Neuro shares in Q3 2020, an estimated $272K.
  • Worth Venture Partners first reported a position in ClearPoint Neuro in Q4 2019 and held it in 3 quarters.
  • Worth Venture Partners's ClearPoint Neuro position peaked at $416K in Q4 2019.
  • 28 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2020.

Based on Worth Venture Partners's 13F filing for Q3 2020, filed 16 Nov 2020.